ACRBP
Acrosin-binding protein
Also known as: ACRBP_HUMAN, CT23, OY-TES-1, SP32
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NEB7
- Gene
- ACRBP
- Ensembl
- ENSG00000111644
- Chromosome
- 12
- Canonical length
- 543 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
The protein encoded by this gene is similar to proacrosin binding protein sp32 precursor found in mouse, guinea pig, and pig. This protein is located in the sperm acrosome and is thought to function as a binding protein to proacrosin for packaging and condensation of the acrosin zymogen in the acrosomal matrix. This protein is a member of the cancer/testis family of antigens and it is found to be immunogenic. In normal tissues, this mRNA is expressed only in testis, whereas it is detected in a range of different tumor types such as bladder, breast, lung, liver, and colon. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
543 residues, UniProt reviewed canonical sequence.
>Q8NEB7|ACRBP
1 MRKPAAGFLP SLLKVLLLPL APAAAQDSTQ ASTPGSPLSP TEYERFFALL TPTWKAETTC
61 RLRATHGCRN PTLVQLDQYE NHGLVPDGAV CSNLPYASWF ESFCQFTHYR CSNHVYYAKR
121 VLCSQPVSIL SPNTLKEIEA SAEVSPTTMT SPISPHFTVT ERQTFQPWPE RLSNNVEELL
181 QSSLSLGGQE QAPEHKQEQG VEHRQEPTQE HKQEEGQKQE EQEEEQEEEG KQEEGQGTKE
241 GREAVSQLQT DSEPKFHSES LSSNPSSFAP RVREVESTPM IMENIQELIR SAQEIDEMNE
301 IYDENSYWRN QNPGSLLQLP HTEALLVLCY SIVENTCIIT PTAKAWKYME EEILGFGKSV
361 CDSLGRRHMS TCALCDFCSL KLEQCHSEAS LQRQQCDTSH KTPFVSPLLA SQSLSIGNQV
421 GSPESGRFYG LDLYGGLHMD FWCARLATKG CEDVRVSGWL QTEFLSFQDG DFPTKICDTD
481 YIQYPNYCSF KSQQCLMRNR NRKVSRMRCL QNETYSALSP GKSEDVVLRW SQEFSTLTLG
541 QFGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACRBP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 271 nTPM
Expression across tissuesHPA
Tissue
- testis: 271 nTPM
- epididymis: 13 nTPM
- thyroid gland: 13 nTPM
- bone marrow: 10 nTPM
- spleen: 8.6 nTPM
- duodenum: 7.9 nTPM
Single-cell type
- platelets: 3,356 nCPM
- early spermatids: 1,191 nCPM
- late primary spermatocytes: 1,163 nCPM
- late spermatids: 939 nCPM
- megakaryocytes: 167 nCPM
- epididymal principal cells: 96 nCPM
Immune cell
- non-classical monocyte: 31 nTPM
- myeloid DC: 18 nTPM
- intermediate monocyte: 16 nTPM
- classical monocyte: 13 nTPM
- total PBMC: 11 nTPM
- plasmacytoid DC: 4.5 nTPM
Brain region
- cerebellum: 3.4 nTPM
- white matter: 2.3 nTPM
- medulla oblongata: 2.2 nTPM
- pons: 2.1 nTPM
- basal ganglia: 1.9 nTPM
- midbrain: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACRBP.
Disease | ImmuneIEDB
Conditions an epitope on ACRBP was assayed in.
- ovarian cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Kazal domain superfamily
- Proacrosin binding sp32
- Proacrosin binding protein sp32
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACRBP as an antibody target. Whether an autoantibody or antibody against ACRBP could matter depends on whether native ACRBP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACRBP is annotated as secreted, so native ACRBP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ACRBP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...